Recent Advances in Inflammation and Allergy Drug Discovery
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.5 | Q4 | 19.9% | 0.391 | Q3 | 52.5% |
| 2024 | 1.1 | Q4 | 15.3% | 0.318 | Q3 | 47.5% |
| 2023 | 1.2 | Q4 | 20.6% | 0.443 | Q3 | 61.0% |
| 2022 | 0.4 | 5.8% | 0.973 | Q1 | 85.7% | |
| 2021 | — | 24.0% | — | 0.0% | ||
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2772-2708
ISSN
2772-2716
region
Middle East
coverage
2021-2025